222 related articles for article (PubMed ID: 19819483)
1. [Anti-optic neuromyelitis IgG antibodies and neuropsychiatric manifestations in systemic lupus erythematosus].
Gómiz Rodrígez G; López Robles C; Callejas Rubio JL; Ortego Centeno N
Med Clin (Barc); 2010 May; 134(13):614. PubMed ID: 19819483
[No Abstract] [Full Text] [Related]
2. Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients.
Ketelslegers IA; Modderman PW; Vennegoor A; Killestein J; Hamann D; Hintzen RQ
Mult Scler; 2011 Dec; 17(12):1527-30. PubMed ID: 21828202
[TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis optica.
Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
[TBL] [Abstract][Full Text] [Related]
4. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
Kovacs KT; Kalluri SR; Boza-Serrano A; Deierborg T; Csepany T; Simo M; Rokusz L; Miseta A; Alcaraz N; Czirjak L; Berki T; Molnar T; Hemmer B; Illes Z
Mult Scler; 2016 Aug; 22(9):1192-201. PubMed ID: 26514978
[TBL] [Abstract][Full Text] [Related]
5. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
Weinshenker BG; Jacob A
Neurology; 2007 Apr; 68(16):1326; author reply 1327. PubMed ID: 17438233
[No Abstract] [Full Text] [Related]
7. NMO-IgG in the diagnosis of neuromyelitis optica.
Jarius S; Franciotta D; Bergamaschi R; Wright H; Littleton E; Palace J; Hohlfeld R; Vincent A
Neurology; 2007 Mar; 68(13):1076-7. PubMed ID: 17287449
[No Abstract] [Full Text] [Related]
8. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
[TBL] [Abstract][Full Text] [Related]
9. Complexity and heterogeneity in demyelinating disease.
Compston A
Brain; 2007 May; 130(Pt 5):1178-80. PubMed ID: 17472981
[No Abstract] [Full Text] [Related]
10. [Neuromyelitis optica and anti-aquaporin 4 antibody].
Tanaka K
Nihon Rinsho; 2015 Sep; 73 Suppl 7():265-70. PubMed ID: 26480711
[No Abstract] [Full Text] [Related]
11. Is neuromyelitis optica distinct from multiple sclerosis?: something for "lumpers" and "splitters".
Frohman EM; Kerr D
Arch Neurol; 2007 Jun; 64(6):903-5. PubMed ID: 17562944
[No Abstract] [Full Text] [Related]
12. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.
Wang KC; Tsai CP; Lee CL; Chen SY; Chen SJ
Eur Neurol; 2011; 65(2):99-104. PubMed ID: 21273778
[TBL] [Abstract][Full Text] [Related]
13. Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseases.
Katsumata Y; Kawachi I; Kawaguchi Y; Gono T; Ichida H; Hara M; Yamanaka H
Mod Rheumatol; 2012 Sep; 22(5):676-84. PubMed ID: 22183613
[TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis optica spectrum disorder and systemic lupus erythematosus.
Thabah MM; D S; Pranov R; Moulitej MMV; Ramesh A; Kadhiravan T
Lupus; 2019 Dec; 28(14):1722-1726. PubMed ID: 31722604
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?
Mader S; Jeganathan V; Arinuma Y; Fujieda Y; Dujmovic I; Drulovic J; Shimizu Y; Sakuma Y; Stern JNH; Aranow C; Mackay M; Yasuda S; Atsumi T; Hirohata S; Diamond B
Arthritis Rheumatol; 2018 Feb; 70(2):277-286. PubMed ID: 29073350
[TBL] [Abstract][Full Text] [Related]
16. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
Wingerchuk DM; Lucchinetti CF
Curr Opin Neurol; 2007 Jun; 20(3):343-50. PubMed ID: 17495631
[TBL] [Abstract][Full Text] [Related]
17. Expanding the spectrum of neuromyelitis optica: friend or foe?
Behbehani R
Curr Opin Ophthalmol; 2007 Nov; 18(6):459-62. PubMed ID: 18162996
[TBL] [Abstract][Full Text] [Related]
18. To test or not to test: NMO-IgG and optic neuritis.
Giovannoni G
Neurology; 2008 Jun; 70(23):2192-3. PubMed ID: 18519868
[No Abstract] [Full Text] [Related]
19. A highly specific and sensitive nanoimmunosensor for the diagnosis of neuromyelitis optica spectrum disorders.
de Souza Moraes A; Brum DG; Ierich JCM; Higa AM; Assis ASJ; Miyazaki CM; Shimizu FM; Peroni LA; Machini MT; Barreira AA; Ferreira M; Oliveira ON; Leite FL
Sci Rep; 2019 Nov; 9(1):16136. PubMed ID: 31695085
[TBL] [Abstract][Full Text] [Related]
20. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
